The Kings and Generals animated historical documentary series on Asian cultures continues with a video on the rise of the Sikh Empire. Following the origins of the Sikhs, this video explores their ...

There is no release date for Farsight: Blade of Truth as of yet but fans who want to learn more about the T’au can check out ...

Yemen’s Houthi rebels fired surface-to-air missiles at a US fighter jet over the Red Sea in the first attack of its kind, Fox News reported Saturday. U.S. military officials are describing the ...

BUFFALO, N.Y. — It is peak flu season, and health officials are urging folks to protect themselves. “Positive lab reports, reported hospitalizations, outpatient illness, mortality and ...

Early indications suggest the much-vaunted economic stabilisation that we have seen since July 2023 is now hitting its peak, and from here on the government will struggle to keep things under control.

With the Nifty50 declining 16 per cent from its peak in September 2024, global brokerage Nomura has projected the index to reach 23,784 by the end of 2025. The Japanese brokerage expects the Nifty ...

Nvidia exited its position in Soundhound AI, causing shares of the small voice AI company to plunge. However, the investing premise for Soundhound AI is the same as before Nvidia's disclosure.

Sam North, market analyst at Etoro, said: 'Centrica's share price tells two contrasting stories: down nearly 70 per cent from its 2013 peak but up over 300 per cent from 2020 lows. 'The key ...

However, global brokerage CLSA has upgraded its rating on the stock, citing favorable valuations and long-term growth prospects. The brokerage has upgraded Tata Motors from ‘Outperform’ to ...

It all began with a tweet. In October 2023, weeks after Israel began bombing Gaza, the writer Omar El Akkad shared a video showing a destroyed city street in Gaza. El Akkad wrote, “One day, when it’s ...

GSK thinks its RSV vaccine can be a £3 billion product at its peak, and is also expecting a similar performance from Blenrep (belantamab mafodotin), recently approved for multiple myeloma ...